CompletedNot Applicable

Post-ICU Follow-up Study in Covid-19 Patients

Sweden793 participantsStarted 2020-10-01

Plain-language summary

A follow up study of adult patients who have been treated in the ICU at Mölndal hospital due to Covid19 in the period of 2020 to 2022.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients treated at the Intensive Care Unit at Mölndals hospital from 2020 to 2022 for Covid19 * More than 3 months passed since ICU discharge * Over 18 years of age at time of inclusion * Swedish resident with Swedish unique personal identification number. * Informed consent Exclusion Criteria: * Under 18 years of age at time of inclusion * Not a Swedish resident * Unwillingness to participate

What they're measuring

Lung Function oxygen saturation

Timeframe: One year

Lung Function, end tidal Co2 in kPa

Timeframe: One year

Lung Function, complete arterial and venous blood gas in kPa

Timeframe: One year

Lung Function spirometry

Timeframe: One year

Lung parenchym status

Timeframe: One year

ECG

Timeframe: One year

Cardiac ultrasound

Timeframe: One year

Cardiac biomarkers Troponin in ng/L

Timeframe: One year

Cardiac biomarkers NTproBNPin ng/L

Timeframe: One year

Trial details

NCT IDNCT05299346

SponsorSahlgrenska University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-06-01

View on ClinicalTrials.gov More COVID-19 Pandemic trials